The activation of SREBPs is primarily regulated by the levels of cellular sterols. When sterol levels are low, SREBPs are activated through a two-step proteolytic process involving Site-1 Protease (S1P) and Site-2 Protease (S2P). This process releases the N-terminal domain of SREBPs, which then translocates to the nucleus to activate target gene expression.